Key Takeaways
- • Signal Labs launches with $25 million in signed total contract value and backing from Lightspeed Venture Partners, positioning itself as a pioneer in a newly defined "Systems of Attention" software category for enterprises.
- • The company's flagship platform, SignalOS™, is engineered to help large organizations identify critical business signals, route them to appropriate decision-makers, and improve institutional decision-making under pressure, with general availability launching April 24, 2026.
- • Founded by healthcare and enterprise technology veteran Rajeev Ronanki, Signal Labs addresses what the CEO characterizes as enterprises' fundamental "attention problem" rather than a technology or AI problem, targeting infrastructure gaps in sectors like healthcare's provider-payer administrative stack.
- • Lightspeed Venture Partners' backing reflects conviction in the company's thesis that scattered organizational signals can be converted into coordinated intelligence across leaders, teams, systems, and AI agents.
Summary
Signal Labs, a newly launched enterprise software startup, has entered the market with $25 million in signed total contract value and institutional backing from Lightspeed Venture Partners. The company is positioning itself to define an emerging category it calls "Systems of Attention"—a new layer of enterprise infrastructure designed to address what founder and CEO Rajeev Ronanki identifies as enterprises' core challenge: coordinating institutional focus and decision-making across dispersed organizational units and AI systems.
The company's core product offering centers on SignalOS™, a platform built to identify the most important signals across an enterprise's business operations, route those signals to appropriate decision-makers, and improve institutional response under pressure. Rather than anchoring its design around traditional dashboard or workflow interfaces, Signal Labs has architected the platform around the problem of attention coordination—determining what matters now, identifying who should act, and calibrating organizational confidence in those decisions. The company announced that Apex, its first generally available release, will launch on April 24, 2026.
Ronanki, who brings extensive background in healthcare and enterprise technology, frames the company's market thesis around infrastructure gaps in high-stakes sectors. According to Galym Imanbayev, Managing Director and Partner at Lightspeed Venture Partners, the firm was drawn to Signal Labs' approach to converting "scattered signals into coordinated intelligence, both within and between stakeholders," with particular emphasis on applications within healthcare's provider-payer administrative ecosystem, where long-standing infrastructure inefficiencies persist.
The launch positions Signal Labs at the intersection of enterprise software architecture and AI coordination—a space where institutional complexity and the proliferation of data sources have outpaced organizations' ability to effectively prioritize and act on critical information. The $25 million in initial contract value demonstrates early enterprise demand for this problem-solving approach.
The company's core product offering centers on SignalOS™, a platform built to identify the most important signals across an enterprise's business operations, route those signals to appropriate decision-makers, and improve institutional response under pressure. Rather than anchoring its design around traditional dashboard or workflow interfaces, Signal Labs has architected the platform around the problem of attention coordination—determining what matters now, identifying who should act, and calibrating organizational confidence in those decisions. The company announced that Apex, its first generally available release, will launch on April 24, 2026.
Ronanki, who brings extensive background in healthcare and enterprise technology, frames the company's market thesis around infrastructure gaps in high-stakes sectors. According to Galym Imanbayev, Managing Director and Partner at Lightspeed Venture Partners, the firm was drawn to Signal Labs' approach to converting "scattered signals into coordinated intelligence, both within and between stakeholders," with particular emphasis on applications within healthcare's provider-payer administrative ecosystem, where long-standing infrastructure inefficiencies persist.
The launch positions Signal Labs at the intersection of enterprise software architecture and AI coordination—a space where institutional complexity and the proliferation of data sources have outpaced organizations' ability to effectively prioritize and act on critical information. The $25 million in initial contract value demonstrates early enterprise demand for this problem-solving approach.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.